Genocea Biosciences Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
-
-
670.00
235.00
-
1,088
Cost of Goods Sold (COGS) incl. D&A
318.00
469.00
-
-
1,516.00
1,088
Gross Income
318.00
469.00
-
-
1,516.00
1,088
SG&A Expense
20,338.00
33,005.00
40,985.00
46,667.00
51,121.00
38,430
EBIT
20,656.00
33,474.00
41,366.00
48,245.00
52,637.00
39,518
Unusual Expense
422.00
1,160.00
-
-
2,618.00
14,757
Non Operating Income/Expense
731.00
308.00
-
-
-
2,029
Interest Expense
459.00
970.00
1,117.00
1,738.00
1,705.00
1,021
Pretax Income
20,806.00
35,296.00
42,483.00
49,573.00
56,710.00
27,811
Consolidated Net Income
22,411.00
35,476.00
42,483.00
49,573.00
56,710.00
27,811
Net Income
22,411.00
35,476.00
42,483.00
49,573.00
56,710.00
27,811
Net Income After Extraordinaries
22,411.00
35,476.00
42,483.00
49,573.00
56,710.00
27,811
Net Income Available to Common
22,411.00
35,476.00
42,483.00
49,573.00
56,710.00
27,811
EPS (Basic)
1.21
2.27
1.74
1.75
1.98
2.69
Basic Shares Outstanding
17,217.10
15,618.00
24,460.00
28,299.00
28,603.00
10,320.10
EPS (Diluted)
1.30
2.27
1.74
1.75
1.98
2.69
Diluted Shares Outstanding
17,217.10
15,618.00
24,460.00
28,299.00
28,603.00
10,320.10
EBITDA
20,338.00
33,005.00
40,315.00
46,432.00
51,121.00
38,430
Non-Operating Interest Income
-
-
-
410.00
250.00
-
Other After Tax Income (Expense)
1,605.00
180.00
-
-
-
-
About Genocea Biosciences
View Profile
